Regeneron Pharmaceuticals, Inc. (REGN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Group 1 - Regeneron is represented by key personnel including Justin Holko, Global Oncology, Hematology Commercial Business Unit Lead, and Izzy Lowy, Clinical Development Unit Head [1] - The presentation begins with forward-looking statements that may include risks and uncertainties affecting Regeneron's projections [2] - Regeneron does not commit to updating any forward-looking statements based on new information or future events [3]